MIC2L1 Activators
Activators of MIC2L1 influence a variety of intracellular signaling pathways to increase its functional activity. For instance, compounds that elevate intracellular cAMP levels, such as direct stimulators of adenylyl cyclase or beta-adrenergic agonists, lead to the activation of protein kinase A (PKA). PKA is well-known to phosphorylate various proteins and could target MIC2L1, thereby enhancing its functionality. Similarly, non-selective inhibitors of phosphodiesterase or selective inhibitors of PDE4 also raise cAMP levels, which in turn could activate MIC2L1 through cascades involving PKA. Additionally, analogs of cAMP that bypass upstream receptor-mediated events have the potential to directly activate MIC2L1 through PKA-dependent pathways. Another class of activators includes compounds that modulate intracellular calcium levels. Calcium ionophores and channel modulators increase the cytosolic concentration of Ca2+, which is a crucial secondary messenger in numerous signaling pathways. The elevation of intracellular Ca2+ can activate MIC2L1 through various Ca2+-dependent mechanisms, including those mediated by calcium/calmodulin-dependent protein kinases or other Ca2+-sensitive proteins.
Further to this, activators that target protein kinase C (PKC) also play a role in the functional upregulation of MIC2L1. Phorbol esters, which are known activators of PKC, could phosphorylate and thereby modulate the activity of MIC2L1 within signal transduction pathways. L-type calcium channel agonists enhance Ca2+ influx, which may also contribute to the activation of MIC2L1 through pathways sensitive to changes in calcium dynamics. Additionally, compounds that interfere with ion homeostasis, such as inhibitors of the Na+/K+-ATPase, indirectly elevate intracellular calcium levels. This increase in Ca2+ could then stimulate signaling pathways that lead to the activation of MIC2L1, demonstrating the interconnected nature of these cellular processes and their ability to converge on the modulation of MIC2L1 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels which can lead to the phosphorylation and activation of MIC2L1. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that elevates intracellular cAMP, potentially enhancing MIC2L1 activation through PKA-mediated pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which could phosphorylate and activate MIC2L1 as part of signal transduction. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective phosphodiesterase inhibitor, increases cAMP levels, potentially promoting MIC2L1 activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Adrenergic receptor agonist, increases cAMP via GPCR signaling, possibly leading to activation of MIC2L1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective PDE4 inhibitor that raises cAMP levels, which may result in the activation of MIC2L1 through downstream effects. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that raises intracellular Ca2+, possibly activating MIC2L1 through Ca2+-dependent signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore, similar to Ionomycin, it may lead to the activation of MIC2L1 by altering Ca2+ signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that bypasses receptor activation, potentially leading to direct activation of MIC2L1 via PKA-dependent pathways. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
Calcium channel modulator that increases intracellular Ca2+, could indirectly activate MIC2L1 through calcium-dependent mechanisms. | ||||||